TargAnox Garners $5,100,000 Series A Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e889f026-4af2-4ce4-89c4-673e6fc06873&Preview=1 -
Date
3/30/2009 -
Company Name
TargAnox -
Mailing Address
101 Huntington Avenue, 4th Floor Boston, MA 02199 -
Company Description
TargAnox is focused on developing drugs to curb a sometimes disease-related biochemical condition called oxidative stress. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$5,100,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Ascent Biomedical Ventures -
Venture Investor
Partners Innovation Fund -
Venture Investor
Partners HealthCare System
